Recruiting now
-
Dual Administration Of Intraperitoneal And Intravenous TROP2-Directed CAR-NK With TGF-Beta Receptor 2 (TGFBR2) Knock Out (KO) Therapy For Colorectal Cancer-Related Peritoneal Carcinomatosis: A Phase 1/2 Trial (“Chip-CRC Trial”)
Phase 2 · 28 people · 1 site in United States · Recruiting now
-
KRAS Neoantigen Nanovaccine as Adjuvant Therapy for Colorectal Cancer/Pancreatic Cancer
Phase 2 · 49 people · 1 site in China · Recruiting now
-
Active Surveillance and Chemotherapy Before Surgery in Treating Participants With Stage II-III Rectal Cancer
Early phase 1 · 120 people · 1 site in United States · Recruiting now
-
Adjuvant Chemotherapy in Clinical Local Advanced CRC Following Preoperational Therapies and pT0-3N0M0 Diagnosis
Not phased · randomised · 650 people · 1 site in China · Recruiting now
-
A Study to Determine the Effect of CT3001 in Patients With Advanced Solid Tumors
Phase 2 · 78 people · 1 site in United States · Recruiting now